GSK3B and cancer: NR2F1-AS1 knockdown reduces cancer cell viability and metastasis and promotes apoptosis; these actions are mediated by the sponging of miR-363 and increased SOX4 expression, resulting in the activation of the PI3K–AKT–GSK-3β pathway [27].